AzTrials
AzTrials

the Focus of This Study is to Measure the Intra- and Interobserver Agreement for the Evaluation of Early Stage EmbryosNCT01802801

Intra- and Interobserver Agreement in the Assessment of Human Embryos

An observational study of the Focus of This Study is to Measure the Intra- and Interobserver Agreement for the Evaluation of Early Stage Embryos, run by University Hospital, Gasthuisberg at 1 site in Belgium.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine the intra- and interobserver agreement. Read more about this study

Who is it for?
Ages 1 day to 3 daysHealthy volunteers can take part
What is being tested?
embryo development
How many people
50 participants
Where
1 siteBelgium
Study dates
Dec 2007to Aug 2009
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 day to 3 days
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: embryos of IVF/ICSI patients

Who may be able to join

  • fertilized embryos

Who cannot join

  • unfertilized embryos

Trial locations and contacts

1 site in 1 country.

Belgium1 site
  • University Hospital Leuven, Catholic University Leuven

    Leuven

Other trials in Belgium

About this study

Official title: Intra-and Inter-observer Agreement in the Morphological Assessment of Human Embryos

The purpose of this study is to determine the intra- and interobserver agreement.

Being tested
embryo development

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • embryo developmentOther

    intra- and inter-observator analysis

Study groups in NCT01802801
Study groupRoleWhat they receive
1Not described
Receives: Other: embryo development

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Evaluation of the intra- and inter-observer variability in the assessement of human embryos

    Variation in observer assessment of embryo characteristics on day 1, 2 and 3 of embryo development. Assessment of these characteristics is standard procedure. Safety and tolerability or efficacy issues are not relevant for this outcome.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Mar 2013 (estimated)
  2. Study startDec 2007
  3. Primary completionJul 2009
  4. Study completionAug 2009

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01802801
Sponsor's protocol ID
GP12122007
Status last verified
Feb 2013
First submitted
25 Mar 2010
Last updated
1 Mar 2013
Results posted
No

Questions about this trial

What is this clinical trial studying?

An observational study of the Focus of This Study is to Measure the Intra- and Interobserver Agreement for the Evaluation of Early Stage Embryos, run by University Hospital, Gasthuisberg at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Mar 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Evaluation of the intra- and inter-observer variability in the assessement of human embryos. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Mar 2013.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in